Clinical experience with continuous glucose monitoring in adults

Diabetes Technology and Therapeutics

Volumn 11, Issue SUPPL.1, 2009, Pages

  Fabiato, Kristin ^a   Buse, John ^a,c   Duclos, Michelle ^a   Largay, Joseph ^a   Izlar, Camille ^a   O'Connell, Thomas ^a   Stallings, Jennifer ^a   Dungan, Kathleen ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD; CHILD; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE; MALE; METABOLISM; METHODOLOGY; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN; LIFE STYLE; MALE; MONITORING, AMBULATORY; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY;

EID: 70349239210     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2009.0004     Document Type: Review

References (46)

1. Ong KL, Cheung BM, Wong LY, Wat NM, Tan KC, Lam KS: Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol 2008;18: 222-229.
2. Haller MJ, Stalvey MS, Silverstein JH: Predictors of control of diabetes: monitoring may be the key. J Pediatr 2004;144:660-661. (Pubitemid 38594771)
3. Kempf K, Neukirchen W, Martin S, Kolb H: Self-monitoring of blood glucose in type 2 diabetes: a new look at published trials. Diabetologia 2008;4:686-688.
4. Poolsup N, Suksomboon N, Jiamsathit W: Systematic review of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients. Diabetes Technol Ther 2008;10(Suppl 1):S-51-S-66.
5. Hirsch IB, Bode BW, Childs BP, Close KL, Fisher WA, Gavin JR, Ginsberg BH, Raine CH, Verderese CA: Self-monitoring of blood glucose (SMBG) in insulin-and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research. Diabetes Technol Ther 2008;10:419-439.
6. Hay LC, Wilmshurst EG, Fulcher G: Unrecognized hypoand hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther 2003;5:19-27.
7. Bode BW, Schwartz S, Stubbs HA, Block JE: Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care 2005;28:2361-2366. (Pubitemid 41384277)
8. FDA approves new glucose monitoring system for diabetics. http://www.fda.gov/bbs/topics/NEWS/NEW00682.html (accessed March 2009).
9. FDA approves new glucose test for adult diabetics. http://www.fda.gov/ bbs/topics/NEWS/2001=NEW00758 .html (accessed March 2009).
10. Ludvigsson J, Hanas R: Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003;111:933-938. (Pubitemid 36542603)
11. Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, Tobian J, Gross T, Mastrototaro J: Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 2004;79:1521-1526. (Pubitemid 39578876)
12. Chico A, Vidal-Ríos P, Subirà M, Novials A: The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemia in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26:1153-1157. (Pubitemid 36929264)
13. Reach G: Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technol Ther 2008;10:69-80. (Pubitemid 351230288)
14. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
15. JDRF CGM Study Group: JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther 2008;10:310-321.
16. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using realtime continuous glucose monitoring. Diabetes Care 2006;29:2730-2732. (Pubitemid 44912209)
17. Bailey TS, Zisser H, Garg SK: Reduction in hemoglobin A1c with real-time continuous glucose monitoring: results from a 12-week study. Diabetes Technol Ther 2007;9:203-210. (Pubitemid 46959785)
18. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA: Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008;10:377-383.
19. Yoo HJ, An HG, Park SY, Ryu OH, Kim HY, Seo JA, Hong EG, Shin DH, Kim YH, Kim SG, Choi KM, Park IB, Yu JM, Baik SH: Use of real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract 2008;82:73-79.
20. Irvine AA, Cox D, Gonder-Frederick L: Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol 1992;11:135-138.
21. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV: Limitations of conventional methods of self monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 1991;24:1858-1862.
22. The Diabetes Research in Children Network (Direc Net) Study Group: Eight-point glucose testing versus the Continuous Glucose Monitoring System in evaluation of glycemic control in type 1 diabetes. J Clin Endocrinol Metab 2005;90:3387-3391.
23. Larsen J, Ford T, Lyden E, Colling C, Mack-Shipman L, Lane J: What is hypoglycemia in patients with well-controlled type 1 diabetes treated by subcutaneous insulin pump with use of the continuous glucose monitoring system? Endocr Pract 2004;10:324-329.
24. Evans ML, Pernet A, Lomas J, Jones J, Amiel SA: Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care 2000;23:893-897. (Pubitemid 30480014)
25. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor. Diabetes Care 2006;29:44-50. (Pubitemid 44033429)
26. Hirsch IB, Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005;19:178-181. (Pubitemid 40615551)
27. Ceriello A: Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005;54:1-7. (Pubitemid 40105088)
28. Hirsch IB: Glycemic variability: it's not just A1c anymore! Diabetes Technol Ther 2005;7:780-783. (Pubitemid 41572082)
29. Cox DJ, Gonder-Frederick L, Ritterband L, Clarke W, Kovatchev BP: Prediction of severe hypoglycemia. Diabetes Care 2007;30:1370-1373. (Pubitemid 46871140)
30. Kilpatrick ES, Rigby AS, Goode K, Atkin SL: Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycemia in type 1 diabetes. Diabetologia 2007;50:2553-2561. (Pubitemid 350060641)
31. Rigla M, Hernando ME, Gómez EJ, Brugués E, García-Sáez G, Capel I, Pons B, de Leiva A: Real-time continuous glucose monitoring together with telemedical assistance improves glycemic control and glucose stability in pump-treated patients. Diabetes Technol Ther 2008;10:194-199. (Pubitemid 351677590)
32. Kovatchev B, Clarke W: Continuous glucose monitoring (CGM) reduces risks for hypo-and hyperglycemia and glucose variability in diabetes [abstract 0086-OR]. http://professional.diabetes.org/Abstracts-Display.aspx?TYP=1&CID= 54075 (accessed March 2009).
33. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, Fowler D, Campbell PJ, Temple RC: Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 2008;337:907-910.
34. Byrne EZ, Zisser HC, Jovanovic L: Continuous glucose monitoring: is it helpful in pregnancy? Curr Diabetes Rev 2008;4:223-226.
35. Chitayat L, Zisser H, Jovanovic? L: Continuous glucose monitoring during pregnancy. Diabetes Technol Ther 2009;11(Suppl 1):S-105-S-111.
36. Hermanns N, Kulzer B, Gulde C, Eberle H, Haak T: Patient reported outcomes of continuous glucose monitoring (CGM) with real time access to glucose values vs. retrospective analysis; a cross-over study [abstract 1883-P]. http://professional.diabetes.org/Abstracts-display.aspx?TYP=1&CID=69716 (accessed March 2009).
37. Bode B, Silver M, Weiss R, Martin K: Evaluation of a continuous glucose monitoring system for home-use conditions. Managed Care 2008;17:40-45.
38. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J: Alarms based on real-time sensor glucose values alert patients to hypo-and hyperglycemia: the Guardian continuous monitoring system. Diabetes Technol Ther 2004;6:105-113. (Pubitemid 38445735)
39. Garg SK, Voelmle MK, Gottlieb P: Feasibility of 10-day use of a continuous glucose monitoring system in adults with type 1 diabetes. Diabetes Care 2009;32:436-438.
40. Cengiz E, Tamborlane WV: A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther 2009;11(Suppl 1):S-11-S-16.
41. Diabetes Research in Children Network (Direc Net) Study Group: Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther 2006;8:318-325.
42. Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, Peters A, Wolpert H: Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring. Diabetes Technol Ther 2008;10:232-244.
43. Diabetes Research in Children Network (Direc Net) Study Group: Use of the Direc Net Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the Free Style Navigator). Pediatr Diabetes 2008;9:142-147.
44. Meneghini E, Grieco G, Camerini M, Mion E, Brambilla MC, Pizzi G, Fossati C, Disoteo O, Bonomo M: Determinants of morning fasting hyperglycemia in type 1 diabetes mellitus: analysis of 700 72-hour continuous glucose monitoring profiles [abstract 403-P]. http://professional.diabetes.org/Abstracts-Display. aspx?TYP=1&CID=70378 (accessed March 2009).
45. Zisser HC, Bevier WC, Jovanovic L: Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus. Diabetes Technol Ther 2007;9:509.
46. Buckingham B, Wilson DM, Lecher T, Hanas R, Kaiserman K, Cameron F: Duration of nocturnal hypoglycemia prior to seizures. Diabetes Care 2008;31:2110-2112.